NCT00014469View on ClinicalTrials.gov

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2000

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Graft Versus Host DiseaseLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG

busulfan

DRUG

melphalan

DRUG

methotrexate

DRUG

tacrolimus

PROCEDURE

allogeneic bone marrow transplantation

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014469 - Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer | Biotech Hunter | Biotech Hunter